Fuan Pharmaceutical (Group) Co., Ltd.

300194

CNE1000011G4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
3.91 ^CNY	+0.51%		+2.09%	-10.73%

May. 28	Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	CI
May. 27	Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024

May 28, 2024 at 03:32 pm EDT

Fuan Pharmaceutical (Group) Co., Ltd. announced on 28 May 2024 the 2023 final profit distribution plan to be implemented (A shares): cash dividend per 10 shares (tax included) of CNY 0.50000000. Record date: 03 June 2024. Ex-date: 04 June 2024.

Payment date: 04 June 2024.

Latest news about Fuan Pharmaceutical (Group) Co., Ltd.

Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024	May. 28	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	May. 27	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	Apr. 24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Fuan Pharm Unit's Hemorrhage Drug Gets Registration Certificate from China's Drug Regulator	Apr. 07	MT
Drugs of Fuan Pharma's Unit Passes Regulatory Evaluation	Feb. 22	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Fuan Pharma Unit Gets Marketing Approval for Two Drugs	23-06-26	MT
Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023	23-05-05	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-31	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Fuan Pharmaceutical Registers New Respiratory Drug	22-10-10	MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Fuan Pharmaceutical Co., Ltd. Announces Management Appointments	21-12-13	CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Fuan Pharmaceutical Co., Ltd.(XSEC:300194) dropped from S&P Global BMI Index	21-06-21	CI
Fuan Pharmaceutical Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021	21-05-07	CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020	21-04-29	CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

Chart Fuan Pharmaceutical (Group) Co., Ltd.

Duration

Period

Chart Fuan Pharmaceutical (Group) Co., Ltd.

More charts

Company Profile

Fuan Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceutical products. The Companyâs main business includes research and development of pharmaceutical products and production and sales of pharmaceutical intermediates, chemical active pharmaceutical ingredients and preparations. The Companyâs products include antibiotics, anti-tumor, specialty medicines and other categories of medicines. The Companyâs other business includes medicine distribution and other businesses. The Company operates its business in the domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
FUAN PHARMACEUTICAL (GROUP) CO., LTD.	-10.73%	642M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.24%	45.32B
OTSUKA HOLDINGS CO., LTD.	+34.85%	24.51B
SANDOZ GROUP AG	+29.56%	16.85B
CIPLA LIMITED	+21.32%	14.62B
ZYDUS LIFESCIENCES LIMITED	+70.51%	14.16B
THE MEDICINES COMPANY	-0.05%	6.79B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.74%	5.82B
STADA ARZNEIMITTEL	-8.87%	5.73B
GEDEON RICHTER	+10.29%	4.93B